Skye Bioscience (SKYE) has released an update.
Skye Bioscience, Inc., a biotechnology firm based in San Diego, has filed a current report with the SEC. The report, dated June 10, 2024, relates to the company’s common stock, which is traded on the Nasdaq Global Market under the ticker symbol SKYE. The submission reaffirms Skye Bioscience’s compliance with securities regulations, maintaining transparency for its investors.
For further insights into SKYE stock, check out TipRanks’ Stock Analysis page.
